Precision Medicine and Pharmacogenomics Flashcards
CYP that metabolizes codeine, hydrocodone, oxycontin, and other opioids
CYP2D6
Metabolism of 5-Fluorouracil
Most is degraded by DPD (dihydropyrimidine dehydrogenase) in liver
The rest goes to inhibit Thymidylate Synthase (pyrimidine synthesis pathway)
Mutations can occur at either DPD or TS
CYP respobsible for metabolizing MDMA and polybrominated diphenylether (flame retardant)
CYP2B
CYP inhibited by SSRI’s and Tamoxifen
CYP2D6
Grapefruit Juice
Inhibits CYP3A4
CYP inhibited by Grapefruit Juice and Cimetidine (H2 blocker)
CYP3A4
DPD variants
Patients with low DPD activity cannot inactivate 5FU, leading to toxic side effects
Deficiency leads to Primary congenital glaucoma
CYP1B1
CYP that can be uncoupled
CYP2E1
TS Variants
There is a polymorphic tandem repeat that can occur with the Thymidylate Synthase gene
Since the gene has higher activity, more drug will be required and patient is more resistant to therapy
Examples of DNA Variants
- Single Nucleotide Polymorphisms
- Larger insertions or deletions
- Chromosomal aberrations (like translocation)
Major CYP in humans that metabolizes over 50% of common drugs
CYP3A4 / CYP3A5
Trimethylaminuria
“Fish odor syndrome” caused by polymorphism in Flavin Monooxygenase FMO3
CYP that metabolizes viagra and oral contraceptives
CYP3A4
CYP that metabolizes Polycyclic Aromatic Hydrocarbons, Retinoic Acid, and Arachidonic Acid
CYP1B1